Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
12 mai 2023 08h00 HE
|
Sunshine Biopharma Inc.
MONTREAL, May 12, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment
28 févr. 2023 07h30 HE
|
Sunshine Biopharma Inc.
MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...